参考资料:The top 20 pharma companies by 2023 revenue.Fierce Pharma.By Kevin Dunleavy.Apr 15, 2024 03:00am. 识别微信二维码,可添加药时空小编 请注明:姓名+研究方向!
诺和诺德的销售额增长率位列榜首，根本原因还是明星产品司美格鲁肽的爆火出圈。诺和诺德在fiercepharma年度收入排名中连续四年位居第17位后，终于在2023年跃升5位，位居第12位。司美格鲁肽虽然爆火，其中司美格鲁肽注射液Ozempic销售额达139.17亿美元，同比增长60%；司美格鲁肽片剂Rybelsus销售额达27.26亿美元，同...
The below list of the top 10 biggest pharma companies in the world in 2024 is ranked by 2023 revenue for pharmaceutical sales only. 1. Pfizer - US$58.5bn 2. Johnson & Johnson - US$54.76bn 3. AbbVie - US$54.32bn 4. Merck & Co - US$53.6bn 5. Roche - US$49.9bn 6. Sanofi - ...
Guangzhou Pharmaceutical Holdings Limited, founded in 1996, is one of the largest pharma group consists of several pharmaceutical companies, they subsidiaries, manufactures and sells Chinese and western medicines. The group also provides Chinese raw medicines, bio-tech products, medical apparatus, packing...
Rank Methodology for Top Pharma Companies 2024 1. The top pharmaceutical companies in the world are considered. 2. Parameters like latest revenues are considered. 3. The brands are ranked by their revenues. This article has been researched & authored by theContent & Research Teamwhich comprises ...
诺和诺德的销售额增长率位列榜首,根本原因还是明星产品司美格鲁肽的爆火出圈。诺和诺德在fiercepharma年度收入排名中连续四年位居第17位后,终于在2023年跃升5位,位居第12位。 司美格鲁肽虽然爆火,其中司美格鲁肽注射液Ozempic销售额达139.17亿美元,同比增长60%;司美格鲁肽片剂Rybelsus销售额达27.26亿美元,同比增长66...
The article presents the top 20 pharmaceutical companies in the U.S. They include Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline, and Roche. It shows the performace and development of these companies in 2008 and 2009 as well as their future growth. The sales, journal ...
在竞争激烈的全球制药行业中,各大药企纷纷通过不断创新和拓展市场来提升自身的收入。近日,知名行业媒体Fierce Pharma发布了2023年全球收入排名TOP 20的制药企业名单,为我们揭示了这一年度内全球制药行业的格局变化。 位居榜首的是强生公司,其以851.6亿美元的营收再次证明了其在全球制药领域的领先地位。这一数字不仅包括...
Johnson & Johnson, Eli Lilly and Co, AbbVie Inc, Novo Nordisk AS, and Merck & Co Inc are the top 5 pharmaceutical companies in the world in 2023 by market cap (as of Mar 31, 2023). Comprehensively, the top 10 pharma companies in the world in 2022 had a market cap of $ 2,...
2023年3月6日太阳制药发布消息称,已经完成了对创新药研发公司Concert Pharmaceuticals的收购,合计金额5.76亿美元。太阳制药看中Concert Pharma的选择性JAK1/2抑制剂deuruxolitinib,或有best in class潜力,目前已经处于3期临床研究阶段,该产品已经获得FDA的突破性疗法认定(治疗斑秃)。